Celecoxib/Cyclodextrin Eye Drop Microsuspensions: Evaluation of In Vitro Cytotoxicity and Anti-VEGF Efficacy for Retinal Diseases
Open Access
- 28 November 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (12) , 2689
Abstract
Celecoxib (CCB), a cyclooxygenase-2 inhibitor, is capable of reducing oxidative stress and vascular endothelial growth factor (VEGF) expression in retinal cells and has been shown to be effective in the treatment of diabetic retinopathy and age-related macular degeneration. However, the ocular bioavailability of CCB is hampered due to its very low aqueous solubility. In a previous study, we developed 0.5% (w/v) aqueous CCB eye drop microsuspensions (MS) containing randomly methylated β-cyclodextrin (RMβCD) or γ-cyclodextrin (γCD) and hyaluronic acid (HA) as ternary CCB/CD/HA nanoaggregates. Both formulations exhibited good physicochemical properties. Therefore, we further investigated their cytotoxicity and efficacy in a human retina cell line in this study. At a CCB concentration of 1000 μg/mL, both CCB/RMβCD and CCB/γCD eye drop MS showed low hemolysis activity (11.1 ± 0.3% or 4.9 ± 0.2%, respectively). They revealed no signs of causing irritation and were nontoxic to retinal pigment epithelial cells. Moreover, the CCB eye drop MS exhibited significant anti-VEGF activity by reducing VEGF mRNA and protein levels compared to CCB suspended in phosphate buffer saline. The ex vivo transscleral diffusion demonstrated that a high quantity of CCB (112.47 ± 37.27 μg/mL) from CCB/γCD eye drop MS was deposited in the porcine sclera. Our new findings suggest that CCB/CD eye drop MS could be safely delivered to the ocular tissues and demonstrate promising eye drop formulations for retinal disease treatment.Keywords
Funding Information
- Thailand Science Research and Innovation Fund Chulalongkorn University (RES_67_000_3300_000, 6305001)
- Asahi Glass Foundation (RES_67_000_3300_000, 6305001)
- Thammasat University Research Unit in Drug, Health Product Development and Application (DHP-DA) (RES_67_000_3300_000, 6305001)
- Second Century Fund (C2F) of Chulalongkorn University (RES_67_000_3300_000, 6305001)
- Office of Academic Affairs, Chulalongkorn University (RES_67_000_3300_000, 6305001)
This publication has 37 references indexed in Scilit:
- Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extractInhalation Toxicology, 2013
- The worldwide epidemic of diabetic retinopathyIndian Journal Of Ophthalmology, 2012
- Expression and Role of VEGF in the Adult Retinal Pigment EpitheliumInvestigative Ophthalmology & Visual Science, 2011
- Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetesExpert Opinion on Drug Delivery, 2010
- Development of the short time exposure (STE) test: An in vitro eye irritation test using SIRC cellsToxicology in Vitro, 2008
- Topical and systemic drug delivery to the posterior segmentsAdvanced Drug Delivery Reviews, 2005
- Periocular routes for retinal drug deliveryExpert Opinion on Drug Delivery, 2004
- Chapter 4: Requirements Concerning Antiseptics for Periorbital, Orbital and Intraorbital Application. 4.5.: Formulation Requirements for the Ophthalmic Use of Antiseptics2002
- Increased expression of angiogenic growth factors in age-related maculopathyBritish Journal of Ophthalmology, 1997
- Hen's egg chorioallantoic membrane test for irritation potentialFood and Chemical Toxicology, 1985